Mant, M.J., Thong, K.L., Birthwhistle, R.V., et al.: Haemorrhagic complications of heparin therapy. Lancet, 1: 1133, 1977.
2.
Pitney, W.R. , Pettit, J.E., Armstrong , L.: Control of heparin therapy. Br. Med. J., 4: 139, 1970.
3.
Basu, D., Gallus, A., Hirsh, J., et al.: A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N. Engl. J. Med., 287: 324, 1972.
4.
Salzman, E.W. , Deykin, D., Shapiro , R.M., et al.: Management of heparin therapy: Controlled prospective trial. N. Engl. J. Med., 202: 1046, 1975.
5.
Jick, H., Slone, D., Borda, T.T., et al.: Efficacy and toxicity of heparin in relation to age and sex . N. Engl. J. Med., 279: 284, 1968.
6.
Glazier, R.L. , Crowell, E.B.: Randomized prospective trial of continuous vs intermittent heparin therapy. J.A.M.A., 236: 1365, 1976.
7.
Norman, C.S. , Provan, J.L.: Control and complications of intermittent heparin therapy. Surg. Gynecol. Obstet., 145: 338, 1977 .
8.
Heiden, D., et al.: Impairment of heparin of primary haemostasis and platelet (14C) hydroxytryptamine release. Br. J. Hematol., 36: 427, 1977.
9.
Mielke, C.H. , Jr., Kaneshiro, M.M., Maher , I.A., et al.: The standardized normal ivy bleeding time and its prolongation by aspirin. Blood, 34: 204, 1969.
10.
Brecher, G. , Cronkite, E.P.: Morphology and enumeration of human blood platelets. J. Appl. Physiol., 3: 365, 1950.
11.
Levine, P.H. : Platelet-function tests: Predictive value . N. Engl. J. Med., 292: 1346, 1975.
12.
Copley, A.L. , Lalich, J.J.: The influence of blood transfusion and injections on bursa pastoris (shepherd's purse) extract on the clot resistance in two hemophiliacs. Am. J. Med. Sci., 204: 665, 1942 .
13.
Borchgrevink, C.F.: Platelet adhesion in vivo in patients with bleeding disorders. Acta. Med. Scand., 2: 231, 1961.
14.
Hjort, P.F. , Borchgrevink, C.F., et al.: Effect of heparin on the bleeding time. Thromb. Diath. Haemorrh., 4: 389, 1960.
15.
Borchgrevink, C.F.: The mechanism of the prolonged bleeding time provoked by dextran sulphate or by excessive doses of heparin. Acta Med. Scand., 3: 365, 1961.
16.
Quick, A.J. , Shanberger, J.N., Stefanini , M.: The effect of heparin on platelets in vivo . J. Lab. Clin. Med., 33: 1424, 1948.
17.
Biggs, R., (Ed.): Human Blood Coagulation, Haemostasis and Thrombosis. Oxford, Blackwell Scientific Publications, 1972, p. 566.
18.
Williams, J.W. , Beutler, E., Erslev , A.J., et al.: Hematology . New York, McGraw-Hill, 1972, p. 1174.
19.
Pitney, W.R. : Heparin therapy and its laboratory control . Br. J. Haematol., 18: 499, 1970.
